RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Fayetteville, AR · Little Rock, AR · +30 more sites
1 recruiting migraine studies with a site in Fayetteville, AR.
Sponsor: AbbVie
Fayetteville, AR · Little Rock, AR · +30 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.